PharmaWeek

May 18, 2013

Events

Implementing an Omics-Ready IT Architecture
June 18, 2013 | 11:00 am | Register Today!

Instant Visualization Drives Creativity: Improve Omics Data Output
Sponsored by Qlucore

A Shared Drug Development and Translational Medicine Data Platform
Sponsored by PerkinElmer

Harnessing Big Data To Power Genomics, A Conversation with Renaissance Computing Institute
Sponsored by EMC Isilon, Intel and UNC

Complete Webinar Listing

The Future of Companion Diagnostics Commercialization Summit
May 22-23, 2013 • Boston, MA

Bio-IT World Asia & Molecular Med Tri-Con Asia
May 28-31, 2013 • Singapore

ChinaBio Partnering Forum 2013
May 29-30, 2013 • Beijing, China

Exploratory Clinical Development World 2013
June 4-6, 2013 • London, UK

Structure-Based Drug Design
June 19-21, 2013 • Boston, MA

BIOBASE User Group Meeting 2013
Thursday, June 20, 2013 • Cambridge, MA

DIA 2013
June 23-27, 2013 • Boston, MA

Pharma Data Analytics Conference
July 10-11, 2013 • Philadelphia, PA

BioPharm America™ 2013
September 17-19, 2013 • Boston, MA

6th Annual BioRepositories and Sample Management Conference
September 25-27, 2013 • Boston, MA

FAST: Functional Analysis & Screening Technologies Congress
October 28-30, 2013 • Cambridge, MA

CIO Life Sciences Summit
December 15-17, 2013 • Scottsdale, AZ

Complete Event Listing

GSK Deals for Epilepsy Drug

Aug. 28—GSK has entered a deal with Valeant to develop and market the epilepsy drug retigabine and other similar compounds. The agreement begins with a $125 million payment and could net Valeant $825 million, sales and royalties. Retigabine has been tested in two Phase III trials for epilepsy and is currently in Phase II trials for post-herpetic neuralgia. CNN Money

Click here to log in.